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Abstract
The RAS small GTPases orchestrate multiple cellular processes. Studies on knock-out mice showed the essential and
sufficient role of K-RAS, but not N-RAS and H-RAS in embryonic development. However, many physiological functions of K-
RAS in vivo remain unclear. Using wild-type and fli1:GFP transgenic zebrafish, we showed that K-ras-knockdown resulted in
specific hematopoietic and angiogenic defects, including the impaired expression of erythroid-specific gene gata1 and ße3-
hemoglobin, reduced blood circulation and disorganized blood vessels. Expression of either K-rasC40 that links to
phosphoinositide 3-kinase (PI3K) activation, or Akt2 that acts downstream of PI3K, could rescue both hematopoietic and
angiogenic defects in the K-ras knockdown. Consistently, the functional rescue by k-ras mRNA was significantly suppressed
by wortmannin, a PI3K-specific inhibitor. Our results provide direct evidence that PI3K-Akt plays a crucial role in mediating
K-ras signaling during hematopoiesis and angiogenesis in vivo, thus offering new targets and alternative vertebrate model
for studying these processes and their related diseases.
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Introduction
RAS mutations are found in at least 20% of all human
malignancies with K-RAS being the most frequently activated
oncogene of all RAS proteins [1], [2]. Most of our understanding
on the function and regulation of RAS stem from the over-
expression of their constitutive active or dominant negative
mutants or the other RAS signaling components. While useful,
such approaches potentially lead to non-physiological effects [3].
Knock-out studies in mouse established that K-RAS is essential
and sufficient for normal development while H-RAS and N-RAS
are dispensable [4–7]. However, such studies could not conclu-
sively identify the exact roles of RAS during normal tissue/organ
development. Nonetheless, use of K-ras
2/2 fetal liver cells had
shown that K-RAS signals to PI3K to regulate differentiation and
proliferation of erythroid progenitor cells [8], [9]. Other evidence
also point to a close functional association between wild type and
oncogenic RAS, whereby wild type RAS could antagonize the
function of oncogenic RAS [10]. All these call for a need to further
address the physiological roles of RAS signaling at both the
cellular and organismic levels.
The zebrafish Danio rerio is fast emerging as an excellent model
for studying gene functions and signaling processes during
development. Here we aim to define the physiological roles of
wild-type K-ras in zebrafish through its specific gene knockdown,
coupled with functional rescues by its pathway-specific mutant,
their downstream effectors, and also the interference of rescue by
pharmacological inhibitors.
Results
Zebrafish K-ras knockdown resulted in defective
hematopoiesis and angiogenesis
First, zebrafish k-ras cDNA (GenBank DQ486868) was isolated
by reverse transcription-PCR. The encoded protein (Figure 1A) is
highly homologous to human K-RAS2B and mouse K-RAS2,
signified by a poly-lysine tract at its C-terminus (Figure 1A–1C). It
is distinct from two other zebrafish Ras, N-ras [11] and BC048875
(Figure 1B and 1C), especially at their 59UTR (supporting
information Figure S1) that allows subsequent use of specific
morpholino to knockdown K-ras. Zebrafish k-ras transcripts were
detected from one-cell stage and continued to be detected
throughout the whole embryos (Figure 1D). In adult, k-ras
expression was detectable in most tissues (supporting information
Figure S2).
To identify the functional role of K-ras in vivo, translation of
endogenous K-ras was suppressed by targeting k-ras mRNA with
its specific antisense morpholino, k-ras-MO1 or k-ras-MO2
(Figure 1A). Optimal dose for microinjection was obtained that
could result in specific defects but without gross lethality and
global defects (materials and methods, Figure 2–Figure 4, and
supporting information Table S1, Movie S1, S2, S3, S4, S5 and
S6). From 24 hpf (hours-post fertilization) onwards, compared to
control embryos, injected embryos showed reduced circulation of
blood cells in the presence of a beating heart, albeit with lower
beating rate (Figure 2A, Figure 2B, supporting information Figure
S3 and Movie S1, S2, S3, S4, S5 and S6). Negligible or fewer
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This phenotype was observed in 76% of k-ras-MO1 injected
embryos (75.8%69.8, n.500, from 15 independent experiments).
Moreover, accumulated red blood cells were often found at sites
away from circulation (Figure 2C). As a negative control, one four-
base mismatch morpholino k-ras-MO1-mis did not cause any of
the above phenotypes as in k-ras-MO1 injected embryos
(supporting information Figure S4). The specificity of K-ras
knockdown was further confirmed by using a second morpholino,
k-ras-MO2 that resulted in similar extents of defects in
hematopoiesis (supporting information Table S1). Furthermore,
the specificity and the efficiency of K-ras knockdown was
confirmed by the reduced level of K-ras, rather than N-ras and
H-ras, protein expression in K-ras MO injected embryos
(supporting information Figure S5), and by the reduced level of
the expression of a red fluorescent protein reporter fused
downstream of k-ras 59UTR in k-ras-MO injected embryos
(supporting information Figure S6). Importantly, when k-ras
mRNA was co-injected with k-ras-MO, such hematopoietic
defects could be rescued effectively (Figure 5A and Figure 5B,
supporting information Table S2), further supporting the specific-
ity of K-ras knockdown. On the other hand, k-ras mRNA failed to
rescue the gastrulation defects induced by the knock down of
RhoA [12] (supporting information Figure S7), another small
GTPase protein, demonstrating the specificity of the k-ras mRNA
and the K-ras knock down.
To further validate the hematopoietic defects, expression of
erythroid-specific genes was examined. In-situ hybridization
Figure 1. Sequence and expression analyses of zebrafish k-ras. (A) Zebrafish k-ras nucleotide and putative amino acid sequence. k-ras-MO1
and k-ras-MO2 binding sites are underlined. (B) Alignment of zebrafish K-ras with known Ras proteins of human, mouse and zebrafish. (C)
Phylogenetic analysis of Ras proteins. (D) k-ras expression during embryonic development. k-ras transcripts were detectable from one cell stage (i)
and then persist throughout the whole embryos (ii–vi). (i), one cell stage, side view; (ii), 3 hpf (hours-post fertilization), top view; (iii), 10 hpf, dorsal
view, anterior to the top; (iv), 10 hpf, bottom view, dorsal to the top; (v), 20 hpf, lateral view, anterior to the left and dorsal to the top; (vi), 20 hpf,
dorsal view, anterior to the left.
doi:10.1371/journal.pone.0002850.g001
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(Figure 3), one well studied erythroid specific gene in early stage
embryo. In addition, some ectopic gata1 expression domains were
observed as well in some embryos. Disrupted gata1 expression was
found in 58% (n=42 in total n=72) knock down embryos. In
agreement with this, when we used ße3-hemoglobin, a gene normally
expressed in differentiating erythrocytes within ICM (intermediate
cell mass) from 15-somite stage, to evaluate the erythroid
development, abnormal ße3-hemoglobin expression was noted in
43% (n=13 in total n=30) of the K-ras knock down embryos,
including either the reduced expression of ße3-hemoglobin or some
ectopic expression of ße3-hemoglobin (Figure 3). It hence indicates
that the disruption of the expression pattern was not due to the
failure of developing erythrocytes to express gata1 or ße3-hemoglobin,
but was due to the loss of developing erythrocytes in ICM and the
misdistribution of the erythrocytes in some ectopic locations.
Consistently, lack of erythrocytes was further confirmed by o-
Dianisidine staining, in agreement with the microscopic analysis
for live embryos (Figure 2A and Figure 2B, supporting information
Movie S1, S2, S3, S4, S5 and S6). Hemoglobinization appeared
normal since all the existing red blood cells, including the
circulating ones which were inside the blood vessels and those
away from the circulation, showed the positive o-Dianisidine
staining.
Since hematopoietic stem cells and angioblasts originate from
bipotential precursors and thus the blood and blood vessel
formation are closely connected in early stage [13], we set out to
examine if the vascular-angiogenesis was also affected by K-ras
knockdown. A vascular-specific transgenic line fli1:GFP, which
allows immediate and direct in-situ monitoring of blood vessel
formation [14] was used. k-ras-MO was injected into fli1:GFP
embryos at 1–4 cell stage. GFP expression was not altered
significantly until 22–24 hpf (Figure 4A). The major vessels, such
as dorsal aorta, caudal artery, posterior cardinal vein and caudal
vein, appeared normal, indicating normal vasculogenesis. But at
later stages, angiogenesis started to be disrupted. By 48 hpf,
Figure 2. Disruption of zebrafish K-ras signaling resulted in the defective hematopoiesis. (A) k-ras-MO injected embryo showed empty
heart, without or with few red blood cells inside (indicated by arrows in ii and iii), in comparison to wild type embryo, which showed plenty of red
blood cells inside the heart (indicated by arrow in i). Embryos at 3 dpf (days-post fertilization). (B) Plenty of circulating red blood cells inside dorsal
aorta (DA), posterior cardinal vein (PCV), inter-segmental vessels (Se), caudal artery (CA) and caudal vein (CV) in wild type embryos (i and iii), while no
or less circulating red blood cells were found in k-ras-MO injected embryos inside DA, PCV, CA, CV and Se (ii and iv). Embryos at 3 dpf. (C) k-ras-MO
injected embryos showed accumulated red blood cells in some sites that away from the circulation. Embryos at 3 dpf. (D) o-Dianisidine staining for
wild type embryo showed hemoglobin positive cells inside branchial arches (indicated by arrow in i) and heart chambers (indicated by arrow in ii ),
while k-ras-MO injected embryo showed less/negative o-Dianisidine staining for branchial arches (indicated by arrow in iii) and heart (indicated by
arrow in iv). Embryos at 6 dpf. (E) o-Dianisidine staining for wild type embryo showed hemoglobin positive cells inside Se (indicated by arrows in i) ,
dorsal longitudinal anastomotic vessels (DLAV), CA and CV (indicated by arrows in ii), while k-ras-MO injected embryo failed to give the positive o-
Dianisidine staining in these corresponding positions (indicated by arrows in iii and iv). Embryos at 6 dpf. All embryos shown are lateral view, with
anterior to the left and dorsal to the top.
doi:10.1371/journal.pone.0002850.g002
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vessels (Figure 4B–i) were replaced by disorganized vascular
channels (Figure 4B–ii to 4B–vi, Figure 4C). Particularly, sub-
intestinal vein (SIV) was examined at 3 dpf (days-post fertilization),
since the well-organized SIV at 72 hpf was regarded as one of the
criteria to evaluate both angiogenic and anti-angiogenic effects
[15] (Figure 4D). There, disorganized SIV, bearing obviously
reduced size/numbers of vessel branches and/or ectopic blood
vessels, accounted for 76% of k-ras-MO1 injected embryos
(76.0%610.2, n=131, from 5 independent experiments) com-
pared to only 17% basal defect level of wild type. Moreover, the
same angiogenic defects could also be induced by k-ras-MO2
(Figure 4B–iii), demonstrating that the angiogenic defects are
specifically resulted from K-ras knockdown. Furthermore, when k-
ras mRNA was co-injected with k-ras-MO, numbers of embryo
with disrupted SIV were reduced significantly (Figure 5).
To further demonstrate the essential role of normal Ras
signaling, k-rasN17, one dominant negative mutant of K-ras,
was expressed in zebrafish embryos. Consistently, it caused similar
hematopoietic and angiogenic defects (Figure 3A–v, 3A–vi, 3B–ii,
Figure 4B–iv and supporting information Table S1), strongly
supporting that the defective hematopoiesis and angiogenesis
result from the disruption of Ras signaling.
PI3K-Akt is important in mediating K-ras signaling for
both hematopoiesis and angiogenesis
Disruption of K-ras signaling caused defective hematopoiesis
and angiogenesis during zebrafish embryonic development.
Subsequently, to determine the involvements of the downstream
effectors of Ras in these two processes, we analyzed the two major
downstream pathways, PI3 Kinase pathway and MAP Kinase
pathway respectively.
Firstly, zebrafish embryos were treated with PI3K inhibitor
wortmannin. Wortmannin (1 mM) was able to cause defective
blood and blood vessel formation, mimicking the defects in K-ras
morphants (supporting information Figure S7, Table S3). This
finding implies that signaling nodes at PI3K-Akt is important for
zebrafish hematopoiesis and angiogenesis, and might be involved
in mediating the downstream signals of K-ras. To prove it, we
examined the ability of this inhibitor at sub-optimal levels to
interfere with the functional rescue by k-ras mRNA for K-ras
knockdown. Indeed, lower concentration of wortmannin
(250 nM), which itself had no effect, could significantly nullify
the rescue ability of k-ras mRNA (Figure 5A). This highlights the
importance of PI3K for mediating K-ras signaling during
hematopoiesis. To substantiate this further, we checked the ability
of functional rescue of K-ras mutant, k-rasC40, which is known to
preferably activate PI3K; and Akt2, which acts downstream of
PI3K [16], [17]. Consistently, k-rasC40 could significantly reduce
the hematopoietic and angiogenic defects caused by K-ras
knockdown (Figure 5B and 5D), and Akt2 also could reduce the
extents of both hematopoietic and angiogenic defects in K-ras
knockdown embryos (Figure 5C and 5E.). Taking together, all
these results demonstrate that the normal signaling from K-ras to
PI3K-Akt is essential for maintaining the normal processes during
hematopoiesis and angiogenesis.
As a comparison, we are also analyzing another major
downstream pathway of Ras, Mek-Erk1/2, which acts down-
stream of Raf [18]. The Mek inhibitor U0126 could not effectively
block the k-ras mRNA rescue for K-ras knockdown at lower doses,
although by itself at a higher dose (10 mM) it was able to induce
the similar defects shown in K-ras morphants (data not shown and
supporting information Figure S8, Table S3). Moreover, the
analysis of the rescue ability of either Mek, or K-ras mutant K-
rasS35, which specifically targets the effector Raf [16], [17],
indicates a complexity of the involvement of Raf/Mek/Erk in
regulating hematopoiesis and angiogenesis. For an example, in the
rescue for hematopoietic defects, the rescue ability of K-rasS35
and Mek1 do not always follow the same trends (supporting
information Figure S9), suggesting the possibility of other
downstream target(s), rather than the Mek, being involved in
mediating the Ras-Raf signaling. Furthermore, when constitutive
active MEK1 (S218D/S222D) was introduced to the rescue, such
mutant already led to global defects in the embryonic development
(data not shown). On the other hand, when U0126 was used at its
sub-optimal levels it did not significantly block the Akt2 rescue
after the K-ras knock-down (data not shown), implying that the
basal Mek/Erk activity may not be necessary for the Akt2 function
in regulating these two processes. More Mek-specific knockdowns
are now being developed in order to better understand the exact
involvements of Mek/Erk either in isolation or in concert with
Akt2.
Figure 3. Disruption of zebrafish K-ras signaling resulted in the disruption of gata-1 and ße3-globin expression. (A) K-ras knockdown or
over-expression of K-ras-N17 resulted in the disruption of gata-1 expression. Embryos at 20 hpf, lateral view, with anterior to the left and dorsal to the
top. (B) K-ras knockdown or over-expression of K-ras-N17 resulted in the disruption of ße3-globin expression. Embryos at 24 hpf, lateral view, with
anterior to the left and dorsal to the top.
doi:10.1371/journal.pone.0002850.g003
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GFP embryos (22 hpf) showed normal development of dorsal aorta and caudal artery (indicted by solid arrows), posterior cardinal vein and caudal
vein (indicated by empty arrows). Higher magnifications of the square area in (i) and (ii) were shown in (iii) and (iv) respectively. (B) Un-injected fli1-
GFP embryo at 3 dpf showed well-organized inter-segmental vessels (i), while k-ras-MO1 injected (ii, v and vi), k-ras-MO2 injected (iii) or k-rasN17
injected (iv) embryos at 3 dpf showed aberrant and irregularly organized inter-segmental vessels. (C) Alkaline phosphatase staining for k-ras-MO1
injected embryos (3 dpf) showed aberrant trunk blood vessels. (D) Alkaline phosphatase staining showed well-organized SIV (sub-intestinal vein,
indicated by arrow) in wild type embryo at 3 dpf (i), while disorganized SIV (indicated by arrow) in k-ras-MO1 injected embryo (ii). Inserted figures in i
and ii showed the anterior part of the embryos. All embryos shown in lateral view, with anterior to the left and dorsal to the top.
doi:10.1371/journal.pone.0002850.g004
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mediating Ras signaling in hematopoiesis and angiogenesis,
zebrafish N-ras was introduced to rescue K-ras knockdown. The
N-ras was shown to confer comparable functional rescue only for
hematopoiesis but not for angiogenesis (Figure 6), thus, suggesting
a unique function of K-ras which is not shared by N-ras. This is in
agreement with the notion that distinct signal outputs from
different RAS isoforms are necessary for diverse biological
responses [19]. In essence, applying targeted gene knockdown
for individual Ras isoforms in zebrafish will help clarify their
distinct mechanisms, establish their relative contributions to
normal physiological functions, and further analyze their potential
Figure 5. PI3K-Akt are crucial mediators for K-ras signaling in zebrafish hematopoiesis and angiogenesis. (A) K-ras knockdown could
be rescued by k-ras mRNA, but this rescue was suppressed by wortmannin at lower dose (250 nM). At this concentration, wortmannin itself could not
induce hematopoietic defects in controlled phenol-red injected group. Embryo numbers n1=37, n2=38, n3=43 and n4=46, from two independent
sets of experiments. (B) Hematopoietic defects caused by K-ras knockdown could be rescued by wild type K-ras and K-ras mutant k-rasC40
respectively. Embryo numbers n1=475, n2=344 and n3=80, from .4 independent sets of experiments. (C) Hematopoietic defects caused by K-ras
knockdown could be rescued by Akt2 effectively. Embryo numbers n1=156 and n2=129, from 4 independent sets of experiment. * indicates
p,0.05. (D) Angiogenic defects caused by K-ras knockdown could be rescued by wild type K-ras and K-ras mutant k-rasC40 respectively. Embryo
numbers n1=133, n2=92 and n3=62, from .2 independent sets of experiments. (E) Angiogenic defects caused by K-ras knockdown could be
rescued by Akt2. Embryo numbers n1=36, n2=20, each group from 2 independent sets of experiments. ** indicates p,0.10. All data are means6SD
(standard deviation). Values indicated by the same letter are not significantly different at p,0.01 for (A) and (B), and at p,0.05 for (D).
doi:10.1371/journal.pone.0002850.g005
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developing the targeted therapeutics without disruption for other
normal RAS signaling. Thus, zebrafish presents a significant
model for faithfully reflecting the in vivo status of Ras signaling,
bypassing the limitation by their over-expression that might re-
route them to ectopic compartments.
Discussion
Previous studies have revealed the roles of RAS in hematopoietic
cell growth and differentiation, but the underlying signaling network
invivois unclear. K-ras knockout mouse resulted in anemiaand normal
RAS signaling was required for erythroid differentiation, while K-
R ASi sth em aj orr egu l ato rfo rAK Tac ti v at io nin vitro [4], [6], [8], [9].
Moreover, oncogenic RAS were known to associate with blood
cancer and other blood disorders [20–22]. One hematopoietic
transcription factor c/EBPß has been linked to RAS, which could be
turned into an activator by RAS/MAPK signaling [23]. Erythro-
poietin (EPO) and Epo-receptor are also found to be able to activate
RAS/RAF/MAPK and PI3K pathways [24]. Studies on human
erythroid progenitors showed importance of PI3K for RAS, MEK
and ERK activation, which were stimulated by EPO through a RAF-
independent way [25]. All these suggest the extensive involvements of
RAS signaling in hematopoiesis and highlight the importance and the
complexity of PI3K-AKT and/or RAF/MEK/ERK in connecting
to and mediating RAS signaling.
Our current studies first establish the in vivo function of PI3K-Akt
as a mediator of K-ras signaling that regulates zebrafish
hematopoiesis. This is consistent with the findings from in vitro
studies in K-ras
2/2 fetal liver cells [9]. Alternatively, this may imply
a potential cross-talk between PI3K and MAP kinase pathways,
such as the studies in hematopoietic progenitor which demonstrated
that MAP kinase pathway through RAS is PI3K-dependent and
that PI3K drives RAF/MEK/ERK activation through RAF by a
yet uncharacterized mechanism [26]. Likewise, it is possible that
Mek/Erk may be under the control of other effectors, including
PI3K, to exert its functional role. More evidence is however
required to address this issue more conclusively.
RAS signaling has also been reported to link to angiogenesis,
especially the tumor-angiogenesis. Oncogenic RAS through RAF/
MEK/ERK and PI3K-AKT have been implicated in controlling
VEGF expression [27]. Here, our results provide strong evidence
that PI3K-Akt is an important common downstream regulator of
K-ras signaling during both hematopoiesis and angiogenesis,
lending further support on the interconnectivity of hematopoiesis
and angiogenesis. Our results therefore supports the potential
value of developing zebrafish as an ideal model for dissecting these
two important biological processes mediated by K-ras signaling. In
summary, our findings have established the important roles of K-
ras signaling in zebrafish hematopoiesis and angiogenesis, with
PI3K/Akt being an important mediator for these two processes.
Within the complexity of Ras and GTPase signaling, it remains an
important issue to determine whether other Ras effector pathways
such as the Raf, Ral and others might be engaged separately or in
concert with the PI3K/Akt. This and further comparative analyses
for the involvement of other Ras isoforms and small GTPases,
should help us better understand the signaling bases of the diseases
in vivo, and to further develop the zebrafish as an alternative model
for therapeutic screens.
Materials and Methods
Fish maintenance
Wild type and transgenic zebrafish were maintained by
standard methods [28]. The transgenic line fli1-GFP was kind
gift from Dr Ge Ruowen and was previously described [14]. All
experiments on zebrafish were carried out at the National
University of Singapore, in accordance with the National Advisory
Committee for Laboratory Animal Research (NACLAR) Guide-
lines and in facilities licensed by the Agri-Food and Veterinary
Authority of Singapore.
Morpholinos
Antisense morpholino oligos (Gene-Tools) were designed to target
the translational start (ATG) of k-ras as k-ras-MO1 and to target the
upstream sequence of ATG in 59UTR as k-ras-MO2 (Figure 1A).
Figure 6. Zebrafish N-ras can rescue hematopoietic defects induced by K-ras knockdown, but not angiogenic defects. (A)
Hematopoietic defects caused by K-ras knockdown could be rescued by zebrafish N-ras effectively. Embryo numbers n1=475, n2=344 and n3=131,
from .3 independent sets of experiments. (B) Angiogenic defects caused by K-ras knockdown could not be rescued by zebrafish N-ras. Embryo
numbers n1=133, n2=92 and n3=151, from 3 independent sets of experiments. All data are means6SD. Values indicated by the same letter are not
significantly different at p,0.05.
doi:10.1371/journal.pone.0002850.g006
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Morpholinos, mRNAs or plasmid constructs (supporting
information for details) were injected into yolk of 1- to 4-cell
stage zebrafish embryos. Doses for injection were titrated with
lower toxicity and higher affectivity. Concentrations for injection
are 600 mM for k-ras-MO1 and k-ras-MO1-mis, 1 mM for k-ras-
MO2, 250 mM for RhoA-MO, 2.5 ng/ml of mRNA for k-ras, n-
ras, k-rasC40 and k-rasS35, 18 ng/ml of mRNA for akt2, 40 ng/ml
for Mek1 and 50 ng/ml for k-rasN17 respectively. Injection
volume is around 2.3 nl.
O-Dianisidine staining and alkaline phosphatase staining
Staining of hemoglobin by o-Dianisidine was carried out as
described [29]. Sub-intestinal vein (SIV) development was
evaluated by alkaline phosphatase staining as described [15].
Inhibitor treatments
Wortmannin (Sigma) and U0126 (Promega) were dissolved in
DMSO as stock and then diluted in egg water before use.
Zebrafish embryos, wild type or injected ones, were treated with
inhibitors from 3–4 hpf at the concentration indicated, controlled
by DMSO treated wild type embryos, or by DMSO treated
injected embryos. Embryos were maintained as standard method.
Criteria for evaluating the status of zebrafish blood and
blood vessel formation
For blood formation, we examined the circulation of live
embryos at 30 hpf and 2 dpf, and then inspected the hemoglobin
by o-Dianisidine staining at 2 dpf. Embryos bearing obvious
reduction in circulation and o-Dianisidine staining in comparison
to their wild type counterparts were regarded as abnormal. For
blood vessel formation, we focused on checking SIV (sub-intestinal
vein, indicated by arrows in Figure 4D) development by alkaline
phosphatase staining at 3 dpf [15]. Embryos with disorganized
SIV baskets, which lost the intact and bear obviously reduced
numbers/size of vessel branches and/or had ectopic blood vessels,
were regarded as abnormal.
Data analysis
All data are presented as mean6SD (standard deviation).
Statistic analysis was performed using one-way ANOVA. Differ-
ences were considered significant at p,0.01, P,0.05 or P,0.10 as
indicated.
More methods were shown in Supporting Information Text S1.
Supporting Information
Figure S1 Comparison of zebrafish k-ras, n-ras and
BC048875. (A) Comparison of amino acid sequences of three
zebrafish Ras proteins, K-ras, N-ras and BC048875. (B)
Alignment of 59UTRs of three zebrafish ras isoforms, k-ras, n-
ras and BC048875. The morpholino targeting sites specific for k-
ras, n-ras and BC048875 were highlighted with shade.
Found at: doi:10.1371/journal.pone.0002850.s001 (10.00 MB
TIF)
Figure S2 Expression analyses of zebrafish k-ras in tis-
sues. RT-PCR analysis of zebrafish k-ras, n-ras and BC048875
expression in adult zebrafish tissues. Most tissues examined, except
spleen, show high or medium level of k-ras expression. Zebrafish
n-ras and zebrafish BC048875 transcripts were also detectable in
all tissues examined at variant levels.
Found at: doi:10.1371/journal.pone.0002850.s002 (0.61 MB TIF)
Figure S3 Reduced heart beat rate was induced by K-ras knock-
down, and it was able to be rescued by k-ras mRNA co-
injection. The observed heart beat rate (per 30 seconds) at
30 hpf (hours-post fertilization) of wild type embryos, k-ras-MO
injected embryos, and k-ras-MO plus k-ras mRNA co-injected
embryos respectively, showing the reduced heart beat rate caused
by K-ras knock-down and the rescue by k-ras mRNA co-injection.
Embryo numbers, n1=30, n2=26 and n3=38. Data are
means6SD (standard deviation), *p,0.05. Values indicated by
the same letter are not significantly different at p,0.05.
Found at: doi:10.1371/journal.pone.0002850.s003 (0.29 MB TIF)
Figure S4 The injection of mis-match k-ras morpholino (k-ras-
MO-mis) could not induce the defects caused by k-ras morpho-
lino. (A) K-ras-MO-mis injected embryos showed significant
difference from K-ras-MO injected embryos by the analysis of
hematopoietic defects. Embryo numbers n1=106, n2=279 and
n3.500 from .2 sets of independent experiments. (B) K-ras-
MO-mis injected embryos showed significant different from K-ras-
MO injected embryos by the analysis of angiogenic defects.
Embryo numbers n1=81, n2=117 and n3=113 from .2 sets of
independent experiments. Data are means6SD. Values indicat-
ed by the same letter are not significantly different at p,0.05.
Found at: doi:10.1371/journal.pone.0002850.s004 (9.96 MB TIF)
Figure S5 Determination of K-ras, N-ras and H-ras protein
level between wild type and k-ras-MO injected embryos. K-ras-
MO injected embryos (1 dpf, one day post fertilization) showed
reduced K-ras protein expression compared to its wild type
control, while the expression of N-ras and H-ras was not affected
significantly, indicating the specificity and efficiency of K-ras
knock-down.
Found at: doi:10.1371/journal.pone.0002850.s005 (10.29 MB
TIF)
Figure S6 RFP expression analysis at 20 hpf for k-ras-59UTR-
RFP injected embryos, indicating the targeting specificity of k-ras
morpholino antisense oligo. (A) Embryo injected with k-ras-
59UTR-RFP/PCS (red fluorescent protein reporter was down
stream of K-ras 59UTR and was cloned into PCS2 vector)
construct, showing strong RFP signal. (B) Embryo co-injected
with k-ras-59UTR-RFP/PCS and k-ras-MO1, showing very weak
RFP signal, indicating the blockage of RFP protein expression by
k-ras-MO1. (C) Embryos from different treatments, showing the
different RFP strength under the same exposure. These embryos
were (i), injected with k-ras-59UTR-RFP/PCS alone; (ii), co-
injected with k-ras-59UTR-RFP/PCS and k-ras-MO1; and (iii),
wild type embryo with no injection.
Found at: doi:10.1371/journal.pone.0002850.s006 (4.05 MB TIF)
Figure S7 k-ras mRNA could not rescue the gastrulation defects
induced by RhoA knock down. RhoA-MO injection can induce
gastrulation defects [12] and these defects could not be rescued by
the co-injection of k-ras mRNA. Embryos were observed at 1-
somite stage. Embryo numbers n1=113, n2=112, from 2 sets of
independent experiments. Data are means6SD. Values indicated
by the same letter are not significantly different at p,0.05.
Found at: doi:10.1371/journal.pone.0002850.s007 (9.69 MB TIF)
Figure S8. PI3K inhibitor wortmannin or MEK inhibitor
U0126 could induce hematopoietic and angiogenic defects similar
to the defects induced by K-ras knock-down. (A) Either
wortmannin or U0126 treatment were able to cause the
hematopoietic defects. These defects include empty heart, with
no or few red blood cells inside heart (indicated by arrows in ii and
iii, compared to wild type in i), reduced or lack of normal
circulation and reduced number of circulating red blood cells
K-ras/PI3K-Akt for Development
PLoS ONE | www.plosone.org 8 August 2008 | Volume 3 | Issue 8 | e2850(indicated by arrows in v and vi, compared to wild type in iv), and
accumulation of blood cells in some sites away from the circulation
(indicated by arrows in vii and viii). All embryos were observed at
4 dpf (days-post fertilization), lateral view, anterior to the left and
dorsal to the top. (B) o-Dianisidine staining for wortmannin or
U0126 treated embryos, showing loss or reduction of hemoglobin
positive cells overall, especially inside heart and in yolk sac
(indicated by empty arrows and block arrows respectively in ii, iii,
v and vi, compared to wild type embryos in i and iv). Except for
grouped embryos, all other embryos are lateral view, anterior to
the left and dorsal to the top. Embryos were observed at
6 dpf. (C) Either wortmannin or U0126 treatment were able to
cause angiogenic defects. Inhibitor treatment for fli1-GFP embryos
resulted in disorganized blood vessels, including the missing
segmental vessels and/or bearing ectopic vessel sprouts (indicated
by arrows in i and ii), similar to the defects caused by K-ras knock-
down. Embryos were observed at 4 dpf, lateral view, anterior to
the left and dorsal to the top.
Found at: doi:10.1371/journal.pone.0002850.s008 (5.06 MB TIF)
Figure S9 Raf is involved in mediating K-ras signaling for both
hematopoiesis and angiogenesis, while Mek might be only
involved in angiogenesis, but not in hematopoiesis. (A) Hema-
topoietic defects caused by K-ras knockdown could be rescued by
wild type k-ras and k-ras mutant k-rasS35 respectively, but not
Mek1. Embryo numbers n1.500, n2=475, n3=142 and
n4=204, from .2 independent sets of experiments. (B)
Angiogenic defects caused by K-ras knockdown could be rescued
by wild type k-ras, k-ras mutant k-rasS35 and Mek1 respectively.
Embryo numbers n1=133, n2=92, n3=39 and n4=89 from .2
independent sets of experiments. All data are means6SD
(standard deviation). Values indicated by the same letter are not
significantly different at p,0.05.
Found at: doi:10.1371/journal.pone.0002850.s009 (7.49 MB TIF)
Movie S1 Beating heart filled with plenty of red blood cells in
wild type embryo. Embryo at 2 dpf (days-post fertilization).
Found at: doi:10.1371/journal.pone.0002850.s010 (6.14 MB
MPG)
Movie S2 Beating heart filled with few red blood cells in k-ras-
MO injected embryo. Embryo at 2 dpf.
Found at: doi:10.1371/journal.pone.0002850.s011 (6.00 MB
MPG)
Movie S3 Plenty of red blood cells circulating inside dorsal aorta
and posterior cardinal vein in wild type embryo. Embryo at 2 dpf.
Found at: doi:10.1371/journal.pone.0002850.s012 (6.41 MB
MPG)
Movie S4 Few red blood cells circulating inside dorsal aorta and
posterior cardinal vein in k-ras-MO injected embryo. Embryo at
2 dpf.
Found at: doi:10.1371/journal.pone.0002850.s013 (7.98 MB
MPG)
Movie S5 Plenty of red blood cells circulating inside caudal
artery and caudal vein in wild type embryo. Embryo at 2 dpf.
Found at: doi:10.1371/journal.pone.0002850.s014 (5.75 MB
MPG)
Movie S6 Few red blood cells circulating inside caudal artery
and caudal vein in k-ras-MO injected embryo. Embryo at 2 dpf.
Found at: doi:10.1371/journal.pone.0002850.s015 (5.75 MB
MPG)
Text S1
Found at: doi:10.1371/journal.pone.0002850.s016 (0.05 MB
DOC)
Table S1 Statistic results summarizing similar hematopoietic
defects induced by k-ras-MO1, k-ras-MO2 and k-ras-N17
respectively, indicating that the hematopoietic defects are closely
related to the disruption of K-ras signaling.
Found at: doi:10.1371/journal.pone.0002850.s017 (0.03 MB
DOC)
Table S2 Hematopoietic defects induced by K-ras knock-down
could be partially rescued by over-expression of k-ras mRNA,
suggesting the specificity of K-ras knock-down.
Found at: doi:10.1371/journal.pone.0002850.s018 (0.03 MB
DOC)
Table S3 Treatments with wortmannin or U0126 for zebrafish
embryos could induce the hematopoietic defects and angiogenic
defects, which phenocopy the functional loss of K-ras.
Found at: doi:10.1371/journal.pone.0002850.s019 (0.03 MB
DOC)
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